These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11752031)

  • 61. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
    Ahuja M; Goumenos D; Shortland JR; Gerakis A; Brown CB
    Am J Kidney Dis; 1999 Sep; 34(3):521-9. PubMed ID: 10469864
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treating IgA Nephropathy - Who, When and How?
    Feehally J
    Nephron Clin Pract; 2003; 93(2):C47-8. PubMed ID: 12616029
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
    Baker LR; Tucker B; Macdougall IC; Oommen R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2704. PubMed ID: 9794596
    [No Abstract]   [Full Text] [Related]  

  • 65. Sequential immunosuppressive therapy in progressive IgA nephropathy.
    Rasche FM; Keller F; von Müller L; Czock D; Lepper PM
    Contrib Nephrol; 2007; 157():109-13. PubMed ID: 17495446
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
    Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
    Kaneko T; Shimizu A; Tsuruoka S; Iino Y; Katayama Y
    J Nippon Med Sch; 2013; 80(4):279-86. PubMed ID: 23995570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
    Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
    J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
    Ni Z; Zhang Z; Yu Z; Lu F; Mei C; Ding X; Yuan W; Zhang W; Jiang G; Sun M; He L; Deng Y; Pang H; Qian J
    Ren Fail; 2021 Dec; 43(1):1214-1221. PubMed ID: 34396911
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy.
    Luo MN; Pan Q; Huang ZQ; Li SM; Xu YZ; Liu HF
    Discov Med; 2020; 30(159):19-25. PubMed ID: 33357359
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
    Frisch G; Lin J; Rosenstock J; Markowitz G; D'Agati V; Radhakrishnan J; Preddie D; Crew J; Valeri A; Appel G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2139-45. PubMed ID: 16030050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.
    Benabdallah L; Rerolle JP; Peraldi MN; Noël LH; Bruneel MF; Carron PL; Morelon E; Kreis H
    Am J Kidney Dis; 2002 Dec; 40(6):E20. PubMed ID: 12460065
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
    Pozzi C; Andrulli S; Del Vecchio L; Melis P; Fogazzi GB; Altieri P; Ponticelli C; Locatelli F
    J Am Soc Nephrol; 2004 Jan; 15(1):157-63. PubMed ID: 14694168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy.
    Nieuwhof C; Kruytzer M; Frederiks P; van Breda Vriesman PJ
    Am J Kidney Dis; 1998 Jun; 31(6):962-70. PubMed ID: 9631840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.